Acta Medical ACTAVBA008 - 100" 20 DROP/ML PRIMARY ADMIN SET, UNIV SPIKE, SLIDE + ROLL CLAMP, 0.2 FILTER, 2 N/F Y-SITE, B/C VALVE, MALE L/L, 50/CS

Acta Medical ACTAVBA008 - 100" 20 DROP/ML PRIMARY ADMIN SET, UNIV SPIKE, SLIDE + ROLL CLAMP, 0.2 FILTER, 2 N/F Y-SITE, B/C VALVE, MALE L/L, 50/CS

100" Primary Administration Set with Universal Spike Drip Chamber (20 drops/ml)

• Slide clamp.
• Roller clamp.
• Back check valve.
• 2 needle free injection sites, 1 at distal end.
• 0.2 micron filter
• Male luer lock.
• Approximate priming volume,13ml.
• Non-DEHP.
• Latex free, Sterile, Pyrogen free.

Back check valve

Prevents backflow and therefore it offers higher safety during parallel pressure and gravity infusions.

For example, at high secondary infusion flow rates, the pressure exerted by the pump can be enough to overcome the primary flow protection offered by the back check valve, causing simultaneous delivery of both the primary and secondary infusions at indeterminate rates. In this unique case, a reduction in secondary infusion flow rate may be required, if possible, or the primary infusion tubing may need to be clamped upstream of the secondary infusion port to obstruct primary fluid flow. The flow rate that overcomes the flow protection of a back check valve varies depending on the specific components (e.g., pump, administration set, IV bag) and the drug connected to the system.

Slide clamp

Slide clamp used to regulate the flow of IV solution. The slide clamp has a graduated opening through which the IV tubing passes. Pushing the tube into the narrow end of the opening constricts it and reduces the flowrate of the IV solution. Sliding the wide end of the opening over the tube increases the flow rate.

Roller clamp

Roller clamp equipped with a small roller that may be rolled counterclockwise to close off primary IV tubing or clockwise to open it. The roller clamp may also be manipulated to increase and decrease the flow of the IVsolution and is easily moved with the thumb, thus making it a one-handed convenience in the administration of IV therapy.

Male Luer

What is a "Luer"?

The Luer taper is a standardized system of small-scale fluid fittings used for making leak-free connections between a male-taper fitting and its mating female part on medical and laboratory instruments, including hypodermic syringe tips and needles or stopcocks and needles.

0.2 Micron Filter

0.2 micron filter is capable of retaining 1 X 10⁷colony forming units of Brevundimonas diminuta per square centimeter of filter, bacteria commonly of a 0.3 micron size.The 0.2 micron filter retains most bacteria, fungus, and particulate matter, but no viruses. 0.2 micron filters is standard in pharmaceutical manufacturing because of its greater (double that of a single 0.2 micron) sterilizing and particle removing capacity..

Pyrogen-free

Pyrogen is any substance that causes a fever. The most commonly thought of pyrogens are bacterial endotoxins and exotoxins, although the host body (human or animal) can also produce pyrogens. The most commonly assayed for pyrogen is lipopolysaccharide, or LPS. It is a component of the bacterial wall of Gram-negative bacteria and is released upon breakdown of the cell wall or bacterial cell lysis.

Pyrogen-free products are manufactured in settings that prevent the deposition of bacteria and other agents on the products.

Patient Safety (DEHP & PVC Free)

PVC-free, DEHP-free products help protect susceptible populations: critically ill male neonates, pregnant and lactating women, pediatric patients, adolescent boys, and chemotherapy patients. Animal toxicity studies indicate that PVC and DEHP target the testes, liver and kidneys.

Infusion Therapy Standards of Practice advise to usee administration sets free of di-ethylhexyl-phthalate (DEHP) to administer lipid-based infusates, such as IVFE or TNA. DEHP is lipophilic and is extracted into the lipid solution with commonly used polyvinyl chloride administration sets and containers. DEHP is considered a toxin, and studies have demonstrated increased DEHP levels in lipid solutions, which is especially a risk with neonatal, pediatric, and long-term home care patients (42).